An Epstein-Barr virus (EBV)-specific DNase was induced in EBV nonproducer Raji cells after treatment with 12-O-tetradecanoylphorbol-13-acetate and sodium butyrate. The increase in EBV DNase activity was related to the appearance of early antigen-positive cells. The enzyme had a sedimentation coefficient of 4S and was resistant to 300 mM KCl, and its induction did not depend on viral DNA synthesis. The EBVspecific DNase activity was specifically inhibited by sera from patients who had nasopharyngeal carcinoma with high early antigen activities but not by sera from normal, healthy individuals. There was a correlation between the degree of anti-EBV DNase activity and the titers of early antigen antibody.
Epstein-Barr virus (EBV), a member of the human herpesvirus family, is associated with infectious mononucleosis (IM), African Burkitt's lymphoma (BL), and undifferentiated nasopharyngeal carcinoma (NPC) (5) . The virus is able to immortalize normal human B lymphocytes into continuously proliferating cell lines carrying the EBV genome, and it is produced in only 1 to 10% of the cells, in contrast with all other human herpesviruses, such as herpes simplex virus, which infects cells lytically and produces a number of virusspecific DNA enzymes such as DNA polymerases (9, 13) , DNases (7) , and thymidine kinases (TK) (8) .
The presence of EBV-specific DNase activity in EBVcarrying lymphoid cell lines in which viral DNA synthesis and subsequent viral production are stimulated has been reported. This is the case for Raji cells superinfected with EBV (2), for EBV producer D98/HR-1 hybrid cells treated with iododeoxyuridine (2) , and for EBV producer P3HR-1 (3, 4) . Biochemical studies have demonstrated that the viral enzyme induced during viral replication differs from cellular enzymes and can be neutralized by sera from NPC patients (1) . This enzyme is absent in EBV nonproducer Raji cells and other virus-negative lymphoid cell lines (2, 3 (12) .
Cells were induced with TPA and SB as previously described (10) . Briefly, all cells were grown to a density of at * Corresponding author. least 2 x 106 cells per ml and diluted to a final concentration of 5 x 105 cells per ml. TPA and SB were added at final concentrations of 20 ng/ml and 2 mM, respectively.
In the preliminary experiments, we characterized the nuclease activity from EBV-negative, EBV producer or nonproducer, and induced or noninduced lymphoid cells. The enzyme activity of the BJAB cells, Raji cells, and P3HR-1 cells was inhibited by KCl to almost 80 to 90% inhibition at 200 mM and 98 to 100% inhibition at 300 mM. In contrast, the activity that was induced after chemical induction of both Raji and P3HR-1 cells was more resistant to KCl, and 20 to 60% of this activity was found to be resistant to 300 mM KCl. The high-salt-resistant nuclease activity, as identified only in induced-cell extracts, had a sedimentation coefficient of 4S, different from the EBV-specific DNA polymerase with a sedimentation coefficient of 8.3S (12) . The optimum condition for the induced activity was a pH of ca. 8.0 in the presence of 3 mM magnesium (data not shown). In these regards, the chemically induced DNase activity has characteristics similar to the EBV-associated DNase activity described by Cheng et al. (2) and Clough (3) in superinfected Raji cells and in producer P3HR-1 cells, respectively.
Studies have shown that EBV-specific DNA enzymes such as DNA polymerase (12) and TK (11) can be induced at an early stage of the Epstein-Barr viral cycle. The synthesis of these enzymes correlates with EA production, suggesting that these enzymes belong to a group of virus-induced early proteins. To know whether viral DNase activity is induced at an early stage of viral replication, the induction of viral DNase activity in different human lymphoid cell lines was studied. The activity, tested in the presence of 300 mM KCl, was only present in P3HR-1 and Raji cells treated with TPA and SB (Table 1 ). In addition, the EBV-specific DNase activity could be induced in P3HR-1 cells treated with TPA-SB plus 1-,3-D-arabinofuranosylthymine, inhibiting completely viral DNA synthesis (10, 11 cultures. This suggests that the EBV DNase is possibly part of the early protein complex, appearing before viral DNA synthesis and related to EA synthesis.
Cheng et al. (2) demonstrated that DNase activity from EBV-superinfected Raji cells can be neutralized by EBVpositive serum, mainly by sera from NPC patients. We examined whether the DNase activity in chemically induced Raji cells was also neutralized by EBV-positive sera. Table 2 summarizes the results obtained with sera from healthy donors, with viral capsid antigen (VCA)-positive sera (from normal adults), with EBV-negative sera, and with sera from patients with EBV-related diseases (NPC, IM, or BL). Striking similarities were observed between the results from our two experiments and those obtained with EBV-superinfected Raji cells (2) . A total of 29 EBV-negative and normal adult sera neutralized only 0 to 7 U of DNase activity. Only 2 of 13 IM sera and 0 of 2 BL sera neutralized more than 7 U of viral DNase. In contrast, 44 of 53 sera from NPC patients neutralized between 8 and 47 U, representing 83% of sera tested in this study.
We examined the neutralization by NPC sera of cellular extracts prepared from EBV-negative BJAB cells. None of these sera neutralized this activity. In this respect, the induced activity in Raji cells seems to be virus specific.
Anti-EBV DNase activity plotted against various EBVspecific antibody titers showed a striking correlation with EA antibody titers (Fig. 1) . The correlation coefficients were 0.75 for EA and 0.6 for VCA. However, the EBV-related antibodies of NPC sera being polyclonal, the high correlation coefficent between EAs and EBV-specific DNase activity does not imply identification of these polypeptides.
This finding raises an important question as to whether viral DNase is one of the constituents of the EA complex. In fact, viral DNase activity and EA-positive cells increased almost in parallel with time after the addition of chemical inducers, and moreover, EBV DNase activity was found only in EA-expressing cultures.
In conclusion, the EBV-induced DNase in Raji cells appears to be a virus-associated enzyme, as supported by the following data: (i) the biochemical properties of this The abscissas indicate the EA or VCA titers. The neutralization assays were done as described in Table 2 , footnote a.
enzyme differ from those of the cellular enzymes found in noninduced cells: (ii) the immunological properties of the enzyme are specifically neutralized by NPC sera; (iii) this type of enzyme activity is absent in EBV-negative lymphoid cells whether treated or not treated by chemical inducers; and (iv) the correlation between the increase in enzyme activity and in the number of EA-positive cells is high. 
